A new biological matrix for septal occlusion

Journal of Interventional Cardiology

Volumn 16, Issue 2, 2003, Pages 149-152

  Jux, Christian ^c   Wohlsein, Peter ^d   Bruegmann, Michael ^a,b   Zutz, M ^d   Franzbach, Birgit ^d   Bertram, Harald ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DACRON; POLITEF; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON DILATATION; BIOCOMPATIBILITY; BIOENGINEERING; BIOPROSTHESIS; CELL INFILTRATION; CONTROLLED STUDY; DEVICE; FOLLOW UP; GRANULATION TISSUE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VIVO STUDY; LAMB; NONHUMAN; PRIORITY JOURNAL; THROMBOGENICITY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 0038636596     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8183.2003.08027.x     Document Type: Article

References (15)

1. Rashkind WJ, Cuaso CC. Transcatheter closure of atrial septal defects in children. Proc Assoc Europ Pediatr Cardiol 1977;13:49.
2. Sharafuddin MJA, Gu X, Titus JL, et al. Transvenous closure of secundum atrial septal defects. Preliminary results with a new self-expanding Nitinol prosthesis in a swine model. Circulation 1997;95:2162-2168.
3. Jux C, Bertram H, Wohlsein P, et al. Experimental proceeding of the STARFlex atrial septal occluder device with autologous cells. J Interv Cardiol 2001;14:309-312.
4. Jux C, Bertram H, Wohlsein P, et al. Experimental ASD closure using autologous cell-seeded interventional closure devices. Cardiovasc Res 2002;53:181-191.
5. Abraham GA, Murray J, Biliar K, et al. Evaluation of the porcine intestinal collagen layer as a biomaterial. J Biomed Mater Res 2000;51:442-452.
6. Voytik-Harbin SL, Brightman AO, Waiser BZ, et al. Small intestinal submucosa: A tissue-derived extracellular matrix that promotes tissue-specific growth and differentiation of cells in vitro. Tissue Eng 1998;4:157-174.
7. Lock JE, Rome JJ, Davis R, et al. Transcatheter closure of atrial septal defects. Experimental studies. Circulation 1989;79:1091-1099.
8. Kuhn MA, Latson LA, Cheatham JP, et al. Biological response to Bard clampshell septal occluders in the canine heart. Circulation 1996;93:1459-1463.
9. Allman AJ, McPherson TB, Badylak SF, et al. Xenogenic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 2001;71:1631-1640.
10. Piccotti JR, Chan SY, VanBuskirk AM, et al. Are Th2 helper lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997;63:619-624.
11. Bach FH, Ferran C, Hechenleiter P, et al. Accommodation of vascularized xenografts: Expression of "protective genes" by donor epithelial cells in a host Th2 cytokine environment. Nature Med 1997;3:196-204.
12. Badylak S, Kokini K, Tullini K. et al. Morphologic study of small intestinal submucosa as a body wall repair device. J Surg Res 2002;103:190-202.
13. Lantz GC, Badylak SF, Hiles MC, et al. Small intestinal submucosa as a vascular graft: A review. J Invest Surg 1993;6:297-310.
14. Huynh T, Abraham G, Murray J, et al. Remodeling of an acellular collagen graft into a physiological responsive neovessel. Nat Biotechnol 1999;17:1083-1086.
15. Cheng EY, Kropp BP. Urologic tissue engineering with small-intestinal submucosa: Potential clinical applications. World J Urol 2000;18:26-30.